Cargando…

Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency

BACKGROUND: Internationally, overdose is the primary cause of death among people injecting drugs. However, since 2001, heroin-related overdose deaths in the United States (US) have risen sixfold, paralleled by a rise in the death rate attributed to synthetic opioids, particularly the fentanyls. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Mars, Sarah G., Ondocsin, Jeff, Ciccarone, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956544/
https://www.ncbi.nlm.nih.gov/pubmed/29769132
http://dx.doi.org/10.1186/s12954-018-0232-z
_version_ 1783323911979532288
author Mars, Sarah G.
Ondocsin, Jeff
Ciccarone, Daniel
author_facet Mars, Sarah G.
Ondocsin, Jeff
Ciccarone, Daniel
author_sort Mars, Sarah G.
collection PubMed
description BACKGROUND: Internationally, overdose is the primary cause of death among people injecting drugs. However, since 2001, heroin-related overdose deaths in the United States (US) have risen sixfold, paralleled by a rise in the death rate attributed to synthetic opioids, particularly the fentanyls. This paper considers the adaptations some US heroin injectors are making to protect themselves from these risks. METHODS: Between 2015 and 2016, a team of ethnographers collected data through semi-structured interviews and observation captured in field notes and video recording of heroin preparation/consumption. Ninety-one current heroin injectors were interviewed (Baltimore, n = 22; Chicago, n = 24; Massachusetts and New Hampshire, n = 36; San Francisco, n = 9). Experience injecting heroin ranged from < 1–47 years. Eight participants, who were exclusively heroin snorters, were also interviewed. Data were analyzed thematically. RESULTS: Across the study sites, multiple methods of sampling “heroin” were identified, sometimes used in combination, ranging from non-injecting routes (snorting, smoking or tasting a small amount prior to injection) to injecting a partial dose and waiting. Partial injection took different forms: a “slow shot” where the user injected a portion of the solution in the syringe, keeping the needle in the injection site, and continuing or withdrawing the syringe or a “tester shot” where the solution was divided into separate injections. Other techniques included getting feedback from others using heroin of the same batch or observing those with higher tolerance injecting heroin from the same batch before judging how much to inject themselves. Although a minority of those interviewed described using these drug sampling techniques, there is clearly receptivity among some users to protecting themselves by using a variety of methods. CONCLUSIONS: The use of drug sampling as a means of preventing an overdose from injection drug use reduces the quantity absorbed at any one time allowing users to monitor drug strength and titrate their dose accordingly. Given the highly unpredictable potency of the drugs currently being sold as heroin in the US, universal precautions should be adopted more widely. Further research is needed into facilitators and barriers to the uptake of these drug sampling methods.
format Online
Article
Text
id pubmed-5956544
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59565442018-05-24 Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency Mars, Sarah G. Ondocsin, Jeff Ciccarone, Daniel Harm Reduct J Research BACKGROUND: Internationally, overdose is the primary cause of death among people injecting drugs. However, since 2001, heroin-related overdose deaths in the United States (US) have risen sixfold, paralleled by a rise in the death rate attributed to synthetic opioids, particularly the fentanyls. This paper considers the adaptations some US heroin injectors are making to protect themselves from these risks. METHODS: Between 2015 and 2016, a team of ethnographers collected data through semi-structured interviews and observation captured in field notes and video recording of heroin preparation/consumption. Ninety-one current heroin injectors were interviewed (Baltimore, n = 22; Chicago, n = 24; Massachusetts and New Hampshire, n = 36; San Francisco, n = 9). Experience injecting heroin ranged from < 1–47 years. Eight participants, who were exclusively heroin snorters, were also interviewed. Data were analyzed thematically. RESULTS: Across the study sites, multiple methods of sampling “heroin” were identified, sometimes used in combination, ranging from non-injecting routes (snorting, smoking or tasting a small amount prior to injection) to injecting a partial dose and waiting. Partial injection took different forms: a “slow shot” where the user injected a portion of the solution in the syringe, keeping the needle in the injection site, and continuing or withdrawing the syringe or a “tester shot” where the solution was divided into separate injections. Other techniques included getting feedback from others using heroin of the same batch or observing those with higher tolerance injecting heroin from the same batch before judging how much to inject themselves. Although a minority of those interviewed described using these drug sampling techniques, there is clearly receptivity among some users to protecting themselves by using a variety of methods. CONCLUSIONS: The use of drug sampling as a means of preventing an overdose from injection drug use reduces the quantity absorbed at any one time allowing users to monitor drug strength and titrate their dose accordingly. Given the highly unpredictable potency of the drugs currently being sold as heroin in the US, universal precautions should be adopted more widely. Further research is needed into facilitators and barriers to the uptake of these drug sampling methods. BioMed Central 2018-05-16 /pmc/articles/PMC5956544/ /pubmed/29769132 http://dx.doi.org/10.1186/s12954-018-0232-z Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Mars, Sarah G.
Ondocsin, Jeff
Ciccarone, Daniel
Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title_full Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title_fullStr Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title_full_unstemmed Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title_short Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
title_sort toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956544/
https://www.ncbi.nlm.nih.gov/pubmed/29769132
http://dx.doi.org/10.1186/s12954-018-0232-z
work_keys_str_mv AT marssarahg tootstastesandtestershotsuseraccountsofdrugsamplingmethodsforgaugingheroinpotency
AT ondocsinjeff tootstastesandtestershotsuseraccountsofdrugsamplingmethodsforgaugingheroinpotency
AT ciccaronedaniel tootstastesandtestershotsuseraccountsofdrugsamplingmethodsforgaugingheroinpotency